C5AR-ANTAGONISTEN

Patent europeic · EP2381778 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2381778
Numer da la dumonda
EP09835688
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
21-12-2009
Publitgà
02-11-2011
Concedì
08-06-2016
La protecziun finescha il pli tard
20-12-2029
Proxima taxa annuala scadenta
31-12-2026
Classas IPC
C07D 211/60 (2006.01)
C07D 401/06 (2006.01)
C07D 401/10 (2006.01)
C07D 401/14 (2006.01)
C07D 405/10 (2006.01)
C07D 413/12 (2006.01)
A61P 37/06 (2006.01)
A61K 31/445 (2006.01)
A61K 31/451 (2006.01)
A61K 31/4545 (2006.01)
A61K 31/5377 (2006.01)
Prioritad
US 139919 P 22.12.2008
Dumonda PCT
PCT/US2009/068941 21.12.2009
Publicaziun PCT
WO2010/075257 01.07.2010
Lingua da l’annunzia
englais
Funtauna
Swissreg

Certificats cumplementars da protecziun

In certificat prolunghescha la protecziun dal patent per in medicament u in product da protecziun da plantas admess en Svizra.

Avacopanum

C02381778/01 · Medicament · Concedì · Protecziun dals 21-12-2029 fin ils 20-12-2034

Admissiun 66772 (Swissmedic, 19-09-2022)

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-01-2026

    Midada

    Published in Swissreg on 01.01.2026

  2. 01-01-2025

    Midada

    Published in Swissreg on 01.01.2025

  3. 01-01-2024

    Midada

    Published in Swissreg on 01.01.2024

  4. 23-05-2023

    Curregì

    Owner
    ChemoCentryx, Inc., One Amgen Drive, Thousand Oaks, CA 91320, USA → ChemoCentryx, Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA

    Published in Swissreg on 23.05.2023

  5. 15-05-2023

    Adressa midada

    Owner
    ChemoCentryx, Inc., 835 Industrial Road Suite 600, San Carlos CA 94070, USA → ChemoCentryx, Inc., One Amgen Drive, Thousand Oaks, CA 91320, USA

    Published in Swissreg on 15.05.2023

  6. 10-01-2023

    Midada

    Published in Swissreg on 10.01.2023

  7. 09-05-2022

    Represchentant stritgà

    Representative
    OFFICE ERNEST T. FREYLINGER S.A., c/o SCHLUEP & DEGEN, P.O. BOX 8062, 3001 Bern (allontanà)

    Published in Swissreg on 09.05.2022

  8. 09-05-2022

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 09.05.2022

3 endataziuns pli veglias
  1. 09-05-2022

    Adressa midada

    Owner
    ChemoCentryx, Inc., 850 Maude Avenue, Mountain View, California 94043, USA → ChemoCentryx, Inc., 835 Industrial Road Suite 600, San Carlos CA 94070, USA

    Published in Swissreg on 09.05.2022

  2. 14-07-2016

    Represchentant inscrit

    Representative
    OFFICE ERNEST T. FREYLINGER S.A., c/o SCHLUEP & DEGEN, P.O. BOX 8062, 3001 Bern

    Published in Swissreg on 14.07.2016

  3. 08-06-2016

    Concedì

    Published in Swissreg on 08.06.2016

Partidas

Possessur

ChemoCentryx, Inc.

One Amgen Center Drive, Thousand Oaks, CA 91320, US

Represchentant

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventur

FAN, Pingchen

Fremont California 94539, US

GREENMAN, Kevin Lloyd

Sunnyvale California 94086, US

LELETI, Manmohan Reddy

Cupertino California 95014, US

LI, Yandong

San Jose California 95127, US

POWERS, Jay

Pacifica California 94044, US

TANAKA, Hiroko

Foster City California 94404, US

YANG, Ju

Cupertino California 95014, US

ZENG, Yibin

Foster City California 94404, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.